Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DURECT Corporation - Common Stock (NQ:DRRX)

1.870 -0.040 (-2.09%)
Streaming Delayed Price Updated: 1:34 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DURECT Corporation - Common Stock

< Previous 1 2 3 4 Next >
Unusual volume stocks are being observed in Wednesday's session.
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Fraud Regulatory Compliance
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout
Bausch Health will acquire DURECT and larsucosterol, aiming for FDA approval of a first treatment for alcoholic hepatitis via Phase 3 trials. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Earnings Scheduled For November 13, 2024
 
Via Benzinga
An Overview of Durect's Earnings
 
Via Benzinga
Earnings Preview: Durect
 
Via Benzinga
Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views
 
Via Benzinga
Topics Earnings
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings
 
Via Benzinga
DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Durect: Q4 Earnings Insights
 
Via Benzinga
Durect's Earnings: A Preview
 
Via Benzinga
Recap: Durect Q3 Earnings
 
Via Benzinga
Shareholder Alert: The Ademi Firm Investigates Whether DURECT Corporation Is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Earnings Scheduled For March 26, 2025
 
Via Benzinga
Durect Earnings Preview
 
Via Benzinga
DRRX Stock Earnings: Durect Beats EPS, Misses Revenue for Q2 2024
DRRX stock results show that Durect beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
DRRX Stock Earnings: Durect Misses EPS, Misses Revenue for Q1 2024
DRRX stock results show that Durect missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
DRRX Stock Earnings: Durect Beats EPS, Beats Revenue for Q4 2023
DRRX stock results show that Durect beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
Top 3 Health Care Stocks That Are Preparing To Pump This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Crude Oil Falls 2.5%; Ralph Lauren Posts Upbeat Earnings
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling around 80 points on Wednesday The Dow traded down 0.23% to 34,074.30 while the NASDAQ fell 0.01% to 13,638.07. The... 
Via Benzinga
Topics Stocks
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.